Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2022-11-25 00:00:00 ET · period of report 2022-11-22 · accession 0001765581-22-000126 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-11-25 | 2022-11-22 | JAZZ | ENRIGHT PATRICK G | Dir | S - Sale | $152.88 | -2,000 | 0 | -100% | -$305.8K |
| M | 2022-11-25 | 2022-11-22 | JAZZ | ENRIGHT PATRICK G | Dir | S - Sale | $149.48 | -4,974 | 21.2K | -19% | -$743.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-11-22 | S | D | 2,000 | $152.88 | 0 | I | — | — | (F3) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $152.84 to $152.91. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. (F4) These shares were held by a trust (the "Trust"). Reporting person is the Trustee of the Trust and may be deemed to share voting, investment and dispositive power over the shares held by the Trust. Reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein and this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purpose. |
| 2 | Common | Ordinary Shares | 2022-11-22 | S | D | 2,069 | $149.90 | 19,112 | D | — | — | (F2) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $149.76 to $150.06. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 3 | Common | Ordinary Shares | 2022-11-22 | S | D | 2,905 | $149.18 | 21,181 | D by Trust | — | — | (F1) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $148.51 to $149.34. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |